Adaptimmune Therapeutics PLC (ADAP)
1.10
-0.10
(-8.33%)
USD |
NASDAQ |
May 17, 16:00
1.10
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Accounts Receivable (Quarterly): 8.404M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.404M |
| December 31, 2023 | 0.821M |
| September 30, 2023 | 0.789M |
| June 30, 2023 | 2.97M |
| March 31, 2023 | 1.715M |
| December 31, 2022 | 7.435M |
| September 30, 2022 | 1.774M |
| June 30, 2022 | 2.382M |
| March 31, 2022 | 1.826M |
| December 31, 2021 | 0.752M |
| September 30, 2021 | 1.641M |
| June 30, 2021 | 2.158M |
| March 31, 2021 | |
| December 31, 2020 | 0.139M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 3.809M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.192M |
| September 30, 2018 | 2.031M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 5.052M |
| December 31, 2017 | 0.206M |
| September 30, 2017 | 4.063M |
| June 30, 2017 | 1.406M |
| March 31, 2017 | 0.107M |
| December 31, 2016 | 1.48M |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.001M |
| September 30, 2015 | 7.759M |
| December 31, 2014 | 6.195M |
| June 30, 2014 | 0.0273M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
8.404M
Maximum
Mar 2024
2.288M
Average
1.744M
Median